title: Monitoring for endometrial disorders in 406 breast cancer women treated by tamoxifen. a low aggressive strategy.
authors.affiliation: Gynaecologic Surgery Department, Jules Bordet Institute, Brussels, Belgium. jmfoidart@ulg.ac.be
authors.forename: M
authors.initials: M
authors.lastname: Vosse
authors.forename: F
authors.initials: F
authors.lastname: Renard
authors.forename: M
authors.initials: M
authors.lastname: Coibion
authors.forename: J M
authors.initials: JM
authors.lastname: Nogaret
authors.forename: D
authors.initials: D
authors.lastname: Hertens
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000009:adverse effects*; D014463:Ultrasonography
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen